Literature DB >> 27825806

Genome scale metabolic modeling of cancer.

Avlant Nilsson1, Jens Nielsen2.   

Abstract

Cancer cells reprogram metabolism to support rapid proliferation and survival. Energy metabolism is particularly important for growth and genes encoding enzymes involved in energy metabolism are frequently altered in cancer cells. A genome scale metabolic model (GEM) is a mathematical formalization of metabolism which allows simulation and hypotheses testing of metabolic strategies. It has successfully been applied to many microorganisms and is now used to study cancer metabolism. Generic models of human metabolism have been reconstructed based on the existence of metabolic genes in the human genome. Cancer specific models of metabolism have also been generated by reducing the number of reactions in the generic model based on high throughput expression data, e.g. transcriptomics and proteomics. Targets for drugs and bio markers for diagnostics have been identified using these models. They have also been used as scaffolds for analysis of high throughput data to allow mechanistic interpretation of changes in expression. Finally, GEMs allow quantitative flux predictions using flux balance analysis (FBA). Here we critically review the requirements for successful FBA simulations of cancer cells and discuss the symmetry between the methods used for modeling of microbial and cancer metabolism. GEMs have great potential for translational research on cancer and will therefore become of increasing importance in the future.
Copyright © 2017. Published by Elsevier Inc.

Entities:  

Keywords:  ATP synthesis; Biomass; Flux

Mesh:

Year:  2016        PMID: 27825806     DOI: 10.1016/j.ymben.2016.10.022

Source DB:  PubMed          Journal:  Metab Eng        ISSN: 1096-7176            Impact factor:   9.783


  28 in total

1.  Elucidating cancer metabolic plasticity by coupling gene regulation with metabolic pathways.

Authors:  Dongya Jia; Mingyang Lu; Kwang Hwa Jung; Jun Hyoung Park; Linglin Yu; José N Onuchic; Benny Abraham Kaipparettu; Herbert Levine
Journal:  Proc Natl Acad Sci U S A       Date:  2019-02-07       Impact factor: 11.205

2.  Exploring the metabolic landscape of pancreatic ductal adenocarcinoma cells using genome-scale metabolic modeling.

Authors:  Mohammad Mazharul Islam; Andrea Goertzen; Pankaj K Singh; Rajib Saha
Journal:  iScience       Date:  2022-05-30

3.  LINE-1 promotes tumorigenicity and exacerbates tumor progression via stimulating metabolism reprogramming in non-small cell lung cancer.

Authors:  Zeguo Sun; Rui Zhang; Xiao Zhang; Yifei Sun; Pengpeng Liu; Nancy Francoeur; Lei Han; Wan Yee Lam; Zhengzi Yi; Robert Sebra; Martin Walsh; Jinpu Yu; Weijia Zhang
Journal:  Mol Cancer       Date:  2022-07-16       Impact factor: 41.444

4.  Machine learning-guided evaluation of extraction and simulation methods for cancer patient-specific metabolic models.

Authors:  Sang Mi Lee; GaRyoung Lee; Hyun Uk Kim
Journal:  Comput Struct Biotechnol J       Date:  2022-06-15       Impact factor: 6.155

Review 5.  Towards the routine use of in silico screenings for drug discovery using metabolic modelling.

Authors:  Tamara Bintener; Maria Pires Pacheco; Thomas Sauter
Journal:  Biochem Soc Trans       Date:  2020-06-30       Impact factor: 5.407

Review 6.  Metabolic Alterations in Cardiopulmonary Vascular Dysfunction.

Authors:  Valérie Françoise Smolders; Erika Zodda; Paul H A Quax; Marina Carini; Joan Albert Barberà; Timothy M Thomson; Olga Tura-Ceide; Marta Cascante
Journal:  Front Mol Biosci       Date:  2019-01-22

7.  A benchmark-driven approach to reconstruct metabolic networks for studying cancer metabolism.

Authors:  Oveis Jamialahmadi; Sameereh Hashemi-Najafabadi; Ehsan Motamedian; Stefano Romeo; Fatemeh Bagheri
Journal:  PLoS Comput Biol       Date:  2019-04-22       Impact factor: 4.475

8.  Personalized Genome-Scale Metabolic Models Identify Targets of Redox Metabolism in Radiation-Resistant Tumors.

Authors:  Joshua E Lewis; Tom E Forshaw; David A Boothman; Cristina M Furdui; Melissa L Kemp
Journal:  Cell Syst       Date:  2021-01-20       Impact factor: 10.304

9.  Stratification of patients with clear cell renal cell carcinoma to facilitate drug repositioning.

Authors:  Xiangyu Li; Woonghee Kim; Kajetan Juszczak; Muhammad Arif; Yusuke Sato; Haruki Kume; Seishi Ogawa; Hasan Turkez; Jan Boren; Jens Nielsen; Mathias Uhlen; Cheng Zhang; Adil Mardinoglu
Journal:  iScience       Date:  2021-06-12

10.  Genome-Scale Modeling of NADPH-Driven β-Lapachone Sensitization in Head and Neck Squamous Cell Carcinoma.

Authors:  Joshua E Lewis; Francesco Costantini; Jade Mims; Xiaofei Chen; Cristina M Furdui; David A Boothman; Melissa L Kemp
Journal:  Antioxid Redox Signal       Date:  2017-09-14       Impact factor: 7.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.